Description
An HCV polymerase inhibitor (Ki = 17 nM); inhibits primer-dependent RNA synthesis selectively over de novo RNA synthesis; inhibits HCV replication in Huh7.5 cells expressing the 1b/Con1 HCV subgenomic replicon (EC50 = 5 nM)
Formal name: 5-(3,3-dimethyl-1-butyn-1-yl)-3-[(cis-4-hydroxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-2-thiophenecarboxylic acid
Synonyms: VX-222
Molecular weight: 445.6
CAS: 1026785-59-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|DNA & RNA Polymerase Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis